Saudi pharmaceutical company to set up production in Uzbekistan for $52 million

Uzbekistan and Saudi Arabia signed 15 agreements for a total of 14 billion USD.

One of them was an agreement with the pharmaceutical company Jamjoom Pharma. Mahmoud Jamjum, vice president of the company, revealed some of its details in a conversation with Arab News.

Under the terms of the agreement, Jamjoom Pharma will invest 52 million USD in Uzbekistan. According to the interlocutor of the agency, the company plans to use the republic as a springboard to enter the markets of the Central Asian states.

Jamjoom Pharma will start working in the Uzbek market immediately after the approval of its application by the authorities. The vice-president of the Saudi company also noted that in the future it is planned to establish production in Uzbekistan.

In April, Shavkat Mirziyoyev instructed to involve large foreign pharmaceutical companies in projects for the production of local medicines. 34 projects in this direction were planned for this year, with a total cost of 80 million USD.